WallStreetZenWallStreetZen

NASDAQ: RGC
Regencell Bioscience Holdings Ltd Earnings & Revenue

OverviewEarnings
DividendOwnership

RGC earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$5.9M
Current Profit Margin
0%

RGC Return on Equity

Current Company
-40.4%
Current Industry
11.8%
Current Market
-0.3%
RGC's Return on Equity (-40.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RGC announces earnings.

RGC Return on Assets

Current Company
-38.3%
Current Industry
3.7%
RGC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RGC Return on Capital Employed

Current Company
-48.87%
Current Industry
6.8%
RGC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RGC vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RGC$0.00-$5.10M-$5.87MN/AN/A
DERM$79.18M$1.92M-$3.85M+22.71%N/A
ASRT$152.07M-$222.45M-$331.94M-13.38%N/A
EGRX$257.55M$57.18M$11.95M+3.61%-14.47%
ETON$32.64M-$291.00k-$936.00k+141.54%N/A
View Top Pharmaceutical Stocks

Regencell Bioscience Holdings Earnings & Revenue FAQ

What were RGC's earnings last quarter?

Regencell Bioscience Holdings (NASDAQ: RGC) reported Q2 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Regencell Bioscience Holdings earnings for the quarter were N/A. In the same quarter last year, Regencell Bioscience Holdings's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Regencell Bioscience Holdings stock.

What was RGC's earnings growth in the past year?

As of Q2 2024, Regencell Bioscience Holdings's earnings has grown year over year. Regencell Bioscience Holdings's earnings in the past year totalled -$5.87 million.

What was RGC's revenue last quarter?

Regencell Bioscience Holdings (NASDAQ: RGC) reported Q2 2023 revenue of N/A up N/A year over year. In the same quarter last year, Regencell Bioscience Holdings's revenue was N/A.

What was RGC's revenue growth in the past year?

As of Q2 2024, Regencell Bioscience Holdings's revenue has grown null year over year. Regencell Bioscience Holdings's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.